09.07.2015 Views

2003; baxter - Supplements - Haematologica

2003; baxter - Supplements - Haematologica

2003; baxter - Supplements - Haematologica

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

104M.S. Vacchio et al.reported that two kinds of anergy can be inducedin vitro, one that is induced by TCR stimulationin the absence of CD28 and is reversible by interleukin-2(IL-2) and the other that is induced byCTLA-4 signals and is not reversible by IL-2. 39The antigen-specific unresponsiveness that wehave observed in H-Y specific transgenic T cellsresembles the second of these anergic states, inthat it is not reversible by IL-2. 33 However in ourmodel of peripheral tolerance, anergy inductiondoes not occur in CD28 knockout mice, despitethe fact that CTLA-4/B7 interactions remainintact in these animals.The dependence on CD28 co-stimulation forthe induction of peripheral tolerance in this systemis in striking contrast to what has beenobserved in CD4 T cells. The observation that H-Y specific T cells did not require CD28 co-stimulationfor activation, as well as the fact thatCD28 is required for peripheral tolerance, haveimportant implications for the development oftolerance-inducing therapies. Because the majorityof work studying the role of CD28 has beenperformed with CD4 T cells, many current therapiesare being designed with the approach thatblockade of CD28 could not only prevent T-cellactivation but induce T-cell anergy. Our workwith CD8 T cells suggests that activation canoccur in the absence of CD28. Moreover, CD28signals can actually be required for toleranceinduction. While our data are representative of asingle antigen-specific T cell, these finding suggestthat activation and tolerance-inductionrequirements can differ between CD4 and CD8T cells; a point to be considered in the design oftolerance-inducing therapies.ConclusionsWhile others have focused on the fetus as anallograft, we have tested the hypothesis that thefetus is responded to as a tissue expressing developmentally-regulatedself antigens, and that T-cell responses to the fetus may be representativeof peripheral mechanisms of T-cell tolerance.Accumulating experimental evidence using antigen-specificsystems to address the fate of maternalT cells upon encounter with fetally-derivedantigens has demonstrated that these cells canundergo several fates. The identified responses ofT cells to the fetal antigens include antigen-specificnon-responsiveness and clonal elimination.These mechanisms are observed in response toself-antigens in other peripheral self-tolerancemodels. Therefore, under normal circumstances,the maternal immune system is not poised toreject the allogeneic fetus, but activates mechanismsthat lead to acceptance of the fetus as self.Using pregnancy as a model to study peripheralT-cell tolerance, we have now attempted to dissectthe role of other co-stimulatory molecules intolerance induction. We find that peripheral toleranceinduction in CD8 T cells in vivo requiresCD28 co-stimulation. A model such as ours canprove useful in the elucidation of peripheral tolerancemechanisms that can ultimately bemanipulated for therapeutic purposes.References1. Kruisbeek AM, Amsen D. Mechanisms underlying T-cell tolerance. Curr Op Immunol 1996;8:233-44.2. Mondino A, Khoruts A, Jenkins MK. The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci USA1996;93:2245-52.3. Kroemer, G. Clonal deletion of self-reactive T cells. InMechanisms of immunological self-tolerance. G. Kroemer,editor. R.G. Landis Co., Austin, Texas, USA. 1994.p. 16-50.4. Kisielow P, Teh HS, Bluthmann H, von Boehmer H. Positiveselection of antigen-specific T cells in thymus byrestricting MHC molecules. Nature 1988;335:730-3.5. Kappler JW, Roehm H, Marrack P. T cell tolerance byclonal elimination in the thymus. Cell 1987;49:273-80.6. Roberts JL, Sharrow SO, Singer A. Clonal deletion andclonal anergy in the thymus induced by cellular elementswith different radiation sensitivities. J Exp Med1990;171:935-40.7. Takahama Y, Shore EW, Singer A. Negative selection ofprecursor thymocytes before their differentiation intoCD4 + CD8 + cells. Science 1992;258:653-6.8. Nieuwenhuis P, Stet RJ, Wagenaar JP, Wubbena AS,Kampinga J, Karrenbeld A. The transcapsular route: anew way for (self-) antigens to by-pass the blood thymusbarrier? Immunol Today 1988;9:372-5.9. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 systemof T cell costimulation. Ann Rev Immunol 1996;14:233-8.10. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansionversus functional clonal inactivation: a costimulatorysignalling pathway determines the outcome of Tcell antigen receptor occupancy. Ann Rev Immunol1989;7:445-80.11. Schwartz RH. A cell culture model of T lymphocyte clonalanergy. Science 1990;248:1349-56.12. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti M, LindstenT, et al. CD28 costimulation can promote T cellsurvival by enhancing the expression of Bcl-XL. Immunity1995;3:87-98.13. Linsley PS, Ledbetter JA. The role of CD28 receptor duringT cell responses to antigen. Ann Rev Immunol 1993;11:191-212.14. Thompson CB, Lindsten T, Ledbetter JA, Kunkel SL,Young HA, Emerson SG, et al. CD28 activation pathwayregulates the production of multiple T cell-derived lymphokines/cytokines.Proc Natl Acad Sci USA 1989;86:1333-7.15. Medawar PB. Some immunological and endocrinologicalproblems raised by the evolution of viviparity in vertebrates.Symp Soc Exp Biol 1954;7:320-38.16. Redline RW, Lu CY. Localization of fetal major histocompatibilitycomplex antigens and maternal leukocytesin murine placenta. Implications for maternal-fetalimmunological relationship. Lab Invest 1989;61:27-36.17. Chaouat G, Menu E. Maternal T cell reactivity in pregnancy?Curr Top Microbiol Immunol 1997;222:103-26.18. Beer AE, Kwak JYH, Ruiz JE. The biological basis of passageof fetal cellular material into the maternal circulation.In Ann NY Acad Sci 1993;8:21-35.19. Bonney EA, Matzinger P. The maternal immune system'sinteraction with circulating fetal cells. J Immunol1997;158:40-7.20. Carbone FR, Kurts C, Bennett SRM, Miller JFAP, HeathWR. Cross-presentation: a general mechanism for CTLimmunity and tolerance. Immunol Today 1998;368:368-73.21. Matzinger P. Tolerance, danger and the extended family.Ann Rev Immunol 1994;12:991-1045.22. Janeway CA, Goodnow CC, Medzhitov R. Immunologicaltolerance: danger - pathogen on the premises! CurrBiol 1996;5:519-22.23. Carter J, Newport A, Keeler KD, Dresser DW. FACSanalysis of changes in T and B lymphocyte populationsin the blood, spleen and lymph nodes of pregnant mice.haematologica vol. 88(supplement n. 12):september <strong>2003</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!